INS and hepatocellular carcinoma: Another study demonstrated that monotherapy with metformin was significantly associated with reduced risk of developing pancreatic cancer and hepatocellular carcinoma compared with taking other anti-diabetic medication such as insulin and sulphonylurea, but not for colon and breast cancer21.